Omnicell appoints Baird Radford as Executive VP and CFO

* Omnicell (NASDAQ:OMCL [https://seekingalpha.com/symbol/OMCL]) announced on Monday the appointment [https://seekingalpha.com/pr/20210694-omnicell-appoints-baird-radford-as-executive-vice-president-and-chief-financial-officer] of Baird Radford as Executive Vice President and Chief Financial Officer, effective August 26, 2025.
* Radford succeeds Nchacha Etta, who will be stepping down from the role, as announced earlier this year. Etta will remain with the company in an advisory role through November 2025 to help ensure a smooth transition of responsibilities.
* Radford most recently served as Chief Financial Officer for Allakos, a biotechnology company focused on developing therapeutic antibodies.
* Prior to Allakos, Radford served as Senior Vice President of Finance for Aimmune Therapeutics, which was acquired by Nestle Health Sciences in late 2020, where he led all aspects of strategic and operational finance activities.

MORE ON OMNICELL

* Omnicell, Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4808000-omnicell-inc-2025-q2-results-earnings-call-presentation]
* Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript [https://seekingalpha.com/article/4807999-omnicell-inc-omcl-q2-2025-earnings-conference-call-transcript]
* Omnicell Q2 Earnings: Market Ignoring The Segments [https://seekingalpha.com/article/4806824-omnicell-q2-earnings-market-ignoring-the-segments]
* Omnicell Q2 2025 Earnings Preview [https://seekingalpha.com/news/4474604-omnicell-q2-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Omnicell [https://seekingalpha.com/symbol/OMCL/ratings/quant-ratings]